Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform developed for COVID-19 vaccines to create the world's first mRNA-based ...

I n December 2020, mRNA vaccines leapt into the limelight as a response to the COVID-19 pandemic. To date, millions of people ...

COVID-19 served as a major catalyst for the widespread adoption of remote patient monitoring, which helps to prevent hospitalizations, improve medication adherence, and enable early interventions by ...

The closest-ever detailed look at a key enzyme inside the virus that causes COVID-19 could lead to more effective treatment ...

Health care workers wheel a Covid-19 patient through a hallway at the Southwestern Vermont Medical Center in Bennington on Dec. 13, 2021. Photo by Glenn Russell/VTDigger This is the first story in a ...

Respiratory viruses that have diverse strains and mutate rapidly, such as influenza and COVID-19, are difficult to block perfectly with vaccines alone. To solve this problem, KAIST's research team has ...

At the height of the COVID-19 pandemic, as we faced lockdowns, quarantine and social distancing, we turned to technology to ...

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...